Why Doximity Shares Are Trading Higher Premarket Today?

Doximity Inc DOCS posted Q3 FY22 sales of $97.9 million, an increase of 67% Y/Y, beating the consensus of $86.27 million.

  • The adjusted EPS of $0.29 came ahead of the consensus of $0.13 and $0.07 a year ago.
  • Non-GAAP net income rose to $63.6 million, versus $19.5 million last year, representing a 65% margin.
  • Adjusted EBITDA of $47.0 million increased 119% Y/Y, representing adjusted EBITDA margins of 48%.
  • Doximity generated an operating cash flow of $27.3 million versus $24.0 million, and a free cash flow of $25.6 million, versus $22.9 million.
  • "We had a strong Q3 led by our existing clients as our net revenue retention rate hit 171%," said Jeff Tangney, co-founder & CEO. "Our telehealth platform grew to 350,000 active providers."
  • Acquisition: Doximity has acquired Amion, an on-call physician scheduling site. Deal terms were not disclosed.
  • Amion manages nearly 200,000 physician schedules at thousands of hospitals.
  • Guidance: For Q4 FY22, Doximity expects revenue of $89.0 million - $90.0 million, compared to the consensus of $89.26 million.
  • It expects adjusted EBITDA of $34.0 million - $35.0 million.
  • For FY22, the Company forecasts revenue of $338.9 million - $339.9 million, versus the consensus of $327.6 million, with adjusted EBITDA of $144.9 million - $145.9 million.
  • The Company also issued interim guidance for FY23 with revenue of approximately $450 million and an adjusted EBITDA margin of over 40%.
  • Price Action: DOCS shares traded 9.17% higher at $54.38 during premarket trading on Wednesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceHealth CareMoversTrading IdeasGeneralBriefswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!